Acoramidis Demonstrates Reversal of Cardiac Structural Disease Progression and Functional Decline and Significantly Increases Days Alive and Free from Hospitalization in ATTR-CM
Go back to Acoramidis Demonstrates Reversal of Cardiac Structural Disease Progression and Functional Decline and Significantly Increases Days Alive and Free from Hospitalization in ATTR-CM| (NASDAQ: BBIO) | Delayed: 66.58 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.58 | 52 Week High | $ | |||
| Open | $66.58 | 52 Week Low | $ | |||
| Day High | $66.58 | P/E | N/A | |||
| Day Low | $66.58 | EPS | $ | |||
| Volume | 816 | |||||
